Background: Exenatide (EXE), a prototypical GLP-1R agonist, has been reported as beneficial to the balance of bone turnover in hyperlipidic and hyperglucidic diet-induced obesity in rats (DIO). Objective: To identify the mediation by GLP-1R of insulin (INS), leptin (LEP), osteocalcin (OCN), calcitonin (CT), carboxy-terminal telopeptide of type 1 collagen (CTX-1), procollagen type 1 amino-terminal propeptide (P1NP) and bone mineral density of femur (BMDF) in DIO. Methods: 72-75-day-old male rats had access only to (i) hyperlipidic food (5.2 kcal/g) and 30% sucrose solution for drinking (1.2 kcal/mL), or (ii) received normocaloric diet (
3
kcal/g) and were allowed to feed and to drink water
ad
libitum. 122-125-day-old rats with 20% overweight were selected from i as obese and those with normal weight were selected from ii as control (
C
) animals. Thus, obese animals remained untreated (DIO) or were treated sc with 100μg of the competitive antagonist of GLP-1R, exendin (
9
-39) (
E
9
) per kg (DIO-
E
9
) daily, for 20 days. Plasma INS, LEP, OCN, CTX-1 (ng/mL), CT and P1NP (pg/mL) were measured by ELISA. BMDF (g/
cm3
) was measured by X-rays.
Results: DIO exhibited similar INS (12.90±1.
83
, n=4) and CT (2.80±1.05, n=4), higher LEP (0.33±0.04, n=5) and lower CTX-1 (0.48±0.
22
, n=
3
) than
C
. The treatment of DIO with
E
9
decreased CTX-1 (4.44±0.63, n=
3
) and increased P1NP (163.40±39.80, n=
3
). DIO-
E
9
decreased INS (5.75±1.50, n=
3
) in relation to DIO, at the same level than
C
(10.58±1.49, n=4). LEP level in DIO-
E
(0.23±0.02, n=
3
) was intermediate in relation to DIO and
C
(0.16±0.05, n=5). OCN, CT and BMDF were similar among
C
, DIO and DIO-
E
9
.
Conclusions: Decreased CTX-1 and normal OCN, P1NP and BMDF reflect a relative normal balance in bone turnover in DIO. Since
E
9
decreases CTX-1, a known effect of EXE in DIO, this alteration on CTX-1 extrapolates the GLP-1R binding and/or EXE and
E
9
act as selective modulators with different actions in different targets. Furthermore,
E
9
increases P1NP (not affected by EXE) and does not affect CT (increased by EXE).
E
9
effects in DIO imply in increased osteoblastic and decreased osteoclastic activities, which promote an imbalance of bone turnover.
Supported by FAPESP, CNPq and CAPES
抄録全体を表示